VITAIRA CONTINUES TO EXPAND ITS EUROPEAN PHARMACEUTICAL LOGISTICS NETWORK WITH PHARMASPED

Munich, 07.10.2026 – By acquiring PharmaSped GmbH, VITAIRA adds another partner to support the expansion of its European specialist logistics group for pharmaceutical and healthcare services. PharmaSped strengthens the existing network with extensive expertise in temperature-controlled pharmaceutical logistics and Europe-wide road transportation, further enhancing VITAIRA’s presence in Southwestern Europe and Italy.

„PharmaSped brings many years of experience and a strong team to the VITAIRA Group. We look forward to combining our capabilities and relationships and jointly creating new opportunities for European pharmaceutical logistics,“ says Andreas Thiede, CEO and Founder of VITAIRA.

VITAIRA Strengthens European Network Through the Acquisition of PharmaSped

With this acquisition, VITAIRA continues to build a European specialist logistics group. Its strategy is to connect companies with complementary capabilities and combine highly regulated services across the pharmaceutical value chain, from freight forwarding to fulfillment, on a Europe-wide scale. Through this approach, VITAIRA is responding to the increasing demands placed on pharmaceutical logistics in Europe. More complex supply chains, growing regulatory requirements, and rising expectations regarding transparency and security of supply require specialized and resilient logistics solutions.

PharmaSped:
Expertise in Temperature-Controlled Pharmaceutical Logistics

Headquartered in Freinsheim, Germany (Rhineland-Palatinate), PharmaSped GmbH specializes in GDP-compliant pharmaceutical transportation and serves customers from the pharmaceutical industry, pharmaceutical wholesalers, and the European re-import and parallel import market. The company has particular expertise in the transportation of temperature-sensitive pharmaceuticals, telematics-based real-time shipment monitoring, and 24/7 logistics surveillance.

Strategic Benefits of the Partnership
The acquisition offers several strategic advantages for VITAIRA:

• Geographic Presence: Expansion of the national network and strengthening of the Southwestern corridor toward Italy
• Pharmaceutical Logistics Expertise: Addition of temperature-controlled pharmaceutical transportation capabilities to the existing service portfolio
• Established Customer Base: Access to direct manufacturer relationships as well as longstanding customers from the pharmaceutical industry, wholesale sector, and import business
• Network Synergies: Integration of PharmaSped’s customer and transportation relationships with VITAIRA’s existing network and warehouse infrastructure
• Market Opportunities: Additional cross-selling potential through the combination of customer relationships and service offerings within the VITAIRA Group

Across Borders:
Strong Partners Pursuing a Common Goal

With VITAIRA HommelPharma serving as the western hub and SCHNEIDER + PEKLAR as the southern hub at Vienna Airport, VITAIRA already has key building blocks of its European network structure in place. VITAIRA HommelPharma strengthens the group’s capabilities in temperature-controlled pharmaceutical logistics, while SCHNEIDER + PEKLAR contributes expertise in freight forwarding and provides connectivity across the DACH region as well as Central and Eastern Europe. Through the addition of PharmaSped, VITAIRA further expands the group with another GDP-focused logistics partner and strengthens the integration of capabilities and markets across Europe.

„Joining VITAIRA provides us with the opportunity to contribute our existing business to a growing European network while unlocking new development opportunities. Our many years of experience and long-standing customer relationships provide a strong foundation for the next stage of growth,“ says Philipp Keil, Managing Director of PharmaSped GmbH.

About VITAIRA

Founded in August 2025, VITAIRA is building a European network of specialized pharmaceutical and transport logistics companies through the acquisition of complementary logistics and transportation businesses. Its objective is to consolidate temperature-controlled pharmaceutical and healthcare services across regulated supply chains on a single platform, ranging from GDP-compliant transportation and warehousing solutions to GMP-certified value-added services. VITAIRA is led by its CEO and Founder, Andreas Thiede. For more information, visit www.vitaira-group.com.

About PharmaSped

PharmaSped GmbH is an internationally active logistics and freight forwarding provider specializing in temperature-controlled and quality-assured pharmaceutical transportation. The company offers customers tailored, highly secure logistics solutions across the entire regulated pharmaceutical supply chain. In addition to specialized pharmaceutical transportation, PharmaSped’s core services include reliable high-value goods logistics, international express and direct transportation, and customized contract logistics solutions. PharmaSped combines many years of industry expertise in European and international transportation with personalized customer service, end-to-end shipment tracking, and digitally enabled real-time processes. Through strict certification under GDP (Good Distribution Practice), ISO 9001, and ISO 14001, PharmaSped ensures the highest quality, security, and temperature standards for sensitive cargo.